Trial Profile
Neural Substrates of Cognitive Deficits in Nicotine Withdrawal
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tolcapone (Primary)
- Indications Smoking withdrawal
- Focus Proof of concept; Therapeutic Use
- 05 Nov 2015 New source identified and integrated (NCT01001520).
- 05 Nov 2015 New trial record